OAO pos: skin
size/s: "Out-of-page"
size/s: "Out-of-page"
OAO pos: top
size/s: "[[[970,250],[970,90],[728,90]],[[728,90]],[[320,50]]]"
size/s: "[[[970,250],[970,90],[728,90]],[[728,90]],[[320,50]]]"
health
297 results tagged health:
How vertical healthcare is reshaping a billion-dollar market
Are telehealth clinics cashing in on your health goals? Uncover the business model behind high-cost weight-loss prescriptions.
Why your insurance through super isn’t always enough
You have insurance in your super, but is it enough to protect your family if a serious illness strikes? This is the cover that many Aussies miss.
SXSW Sydney 2025: Five innovations changing how we live
Which Aussie startup could change how you save, invest or plan for the future? These five SXSW standouts are tackling real-life challenges.
Dental and IVF drive surge in super withdrawals
The amount of money Aussies are taking out of super accounts to pay for dental and IVF treatments has jumped significantly in the year to June 30.
Travel insurance and pre-existing conditions: What you need to know
Travellers who fail to declare pre-existing health conditions risk having their travel insurance claims denied, but what exactly is a pre-existing condition?
Why the market may be wrong about Healius shares
Healius shares are down 75% from peak, but signs point to a potential turnaround for Australia's number two pathology services operator.
Why Australia’s tobacco tax sparked a black market boom
Cigarettes now cost $55 a pack. Is Australia's tax policy fueling a billion-dollar black market?
Monash IVF shares plunge after latest embryo mix-up
Monash IVF is back in the headlines, and for all the wrong reasons. Shares plunged 25% following news of a second embryo mix-up. For many investors, it's déjà vu.
The dodgy dentist who defrauded people of their super
Aussies have been warned after desperate dental patients drained their superannuation balances to pay more than $70,000 for dental care they never received.
Is now the time to buy, hold or sell ResMed shares?
The arrival of weight-loss drugs like Ozempic rattled ResMed shareholders but so far the fear has been misplaced, writes Jun Bei Liu.
Money Newsletter
OAO pos: half_page
size/s: "[[[300,600],[],[[300,600]]]]"
size/s: "[[[300,600],[],[[300,600]]]]"